Market Tracker

08/29 6:01pm ET

Nektar Therapeutics (NASDAQ:NKTR)

14.26
Data as of Aug 29
 -0.05 / -0.35%
Today’s Change
8.87
Today|||52-Week Range
15.34
+25.64%
Year-to-Date

Today’s Trading

Previous close14.31
Today’s open14.36
Day’s range14.17 - 14.52
Volume646,042
Average volume (3 months)1,150,659
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+53.84%
Earnings growth (next 5 years)+31.00%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co+0.82+1.68%
KERXKeryx Biopharmaceuti...+0.38+2.13%
DYAXDyax Corp+0.19+1.90%
ARIAARIAD Pharmaceutical...+0.06+0.97%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.39
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts